Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabMartin Gunnarsson, Jan Lycke, Charlotte Dahle et al.|Annals of Neurology|2010Cited by 347
Neurofilament and glial fibrillary acidic protein in multiple sclerosisNiklas Norgren, Martin Gunnarsson, Peter Sundström et al.|Neurology|2004Cited by 245